Is Prescience, Inc. profitable in 2026?

No revenue, customer count, or profitability data has been disclosed. As of July 2026, Prescience is a 2-person, pre-seed YC S26 startup whose only public traction claim is an unverified statement it is 'helping some ambitious companies save money,' with no figures attached.

Could AI replace Prescience's core product?

Yes, this is a live risk: Prescience's 'Time Machine' underwriting and care-routing engine is described only in marketing terms (an 'AlphaGo-like system') with no disclosed technical specifics, frontier-model partnership, or proprietary data moat as of July 2026, making it replicable.

Who are Prescience's biggest competitors?

Direct AI-native peers include Sana Benefits (founded 2017, partnered with PerfectQuote in March 2026) and Arlo (raised $4M in March 2025 for AI underwriting), plus Gravie and Centivo, and incumbents UnitedHealthcare, Cigna, Aetna, and Blue Cross Blue Shield who already sell level-funded plans.

Who owns Prescience, Inc.?

Prescience is privately, founder-owned by Rishab Jain and Aditya Jain, backed by Y Combinator as part of the Summer 2026 (S26) batch. No external funding amount, valuation, or additional investors have been disclosed as of July 2026.

Where is Prescience, Inc. headquartered?

Its headquarters city is unresolved: YC's own directory lists Boston, while a third-party aggregator and the company's own Jobs sub-page list San Francisco, as of July 22, 2026. No source definitively confirms one location.

Has Prescience raised a seed round?

No confirmed funding amount has been reported. Prescience is part of Y Combinator's Summer 2026 batch, which typically includes standard seed investment, but no specific dollar figure or investor names have been disclosed as of July 22, 2026.

YC Summer 2026 · United States

Prescience, Inc.

AI-native health benefits platform for employers using level-funded plans.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: Seed round or broker distribution deal announcement following YC S26 Demo Day

The call

A two-person team is pitching an AI underwriting layer into a market where bigger, licensed players already sell the same plan type.

Prescience uses AI to route patients to the right care and make underwriting decisions for employer health plans, trying to cut costs by 20 to 50 percent. The company is hard to distinguish from better-funded rivals like Sana Benefits and Arlo, which have been around longer, have relationships with insurance brokers, and own years of claims data; plus, big insurers like UnitedHealthcare and major AI models like Claude could copy the core AI layer fairly easily. The picture changes only if regulators crack down on Prescience's underwriting practices before it proves compliance, or if a rival secures major funding and broker deals that lock customers in.

Why

AI pressure: Frontier models like Claude and GPT-5 replicating the care-routing/underwriting layer. The LLM layer that routes care and prices risk is the kind of thin wrapper frontier labs ship themselves. Could AI do the core job? Yes, likely.

Bigger players: UnitedHealthcare, Aetna, Cigna, Blue Cross Blue Shield. These insurers already sell level-funded SKUs and can add AI underwriting without cannibalizing their core book. Could a giant copy it? Yes, easily.

What protects it. None found: no state licensure, no stop-loss deal, no broker distribution, no audited claims data disclosed yet.

What would change this call

Sana Benefits, Arlo, Gravie, or Centivo announces a new funding round or broker-distribution deal within 6 months. Would show established rivals extending their distribution lead before Prescience gains traction.
Prescience discloses state insurance licensure, a stop-loss reinsurance partner, or an audited loss-ratio result. Would show Prescience building the regulatory and risk infrastructure it currently lacks.
Prescience publishes a named, verifiable customer logo or a signed employer contract. Would show real market adoption beyond the mock Acme, Inc. demo content.

Key numbers

2 person team, no public job postings (2026-07-22)
Rival Arlo raised $4M for AI underwriting (2025-03-25)
Demo shows $847 vs $1213 PMPM, unverified (2026-04-30)

Named risks

No evidence of state insurance licensure for underwriting real risk. Severity: high
Only 2-person team with no jobs posted, high execution risk against stated industry-wide ambition. Severity: high
Core AI underwriting/care-routing layer has no disclosed technical moat, replicable by rivals or frontier models. Severity: high
All product savings and compliance claims are vendor-authored and unverified by independent audit. Severity: medium
Headquarters location unresolved between Boston and San Francisco across sources. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Sana Benefits	gaining on	Partnered with PerfectQuote broker platform, announced March 2026
Arlo	gaining on	Raised $4M for AI-powered underwriting, March 2025
UnitedHealthcare, Cigna, Aetna, Blue Cross Blue Shield	contesting	Already sell own level-funded plans, can enter AI underwriting without conflict
Gravie, Centivo	contesting	Named as active level-funded/alternative-payer competitors as of March 2025

Questions people ask

Is Prescience, Inc. profitable in 2026?: No revenue, customer count, or profitability data has been disclosed. As of July 2026, Prescience is a 2-person, pre-seed YC S26 startup whose only public traction claim is an unverified statement it is 'helping some ambitious companies save money,' with no figures attached.
Could AI replace Prescience's core product?: Yes, this is a live risk: Prescience's 'Time Machine' underwriting and care-routing engine is described only in marketing terms (an 'AlphaGo-like system') with no disclosed technical specifics, frontier-model partnership, or proprietary data moat as of July 2026, making it replicable.
Who are Prescience's biggest competitors?: Direct AI-native peers include Sana Benefits (founded 2017, partnered with PerfectQuote in March 2026) and Arlo (raised $4M in March 2025 for AI underwriting), plus Gravie and Centivo, and incumbents UnitedHealthcare, Cigna, Aetna, and Blue Cross Blue Shield who already sell level-funded plans.
Who owns Prescience, Inc.?: Prescience is privately, founder-owned by Rishab Jain and Aditya Jain, backed by Y Combinator as part of the Summer 2026 (S26) batch. No external funding amount, valuation, or additional investors have been disclosed as of July 2026.
Where is Prescience, Inc. headquartered?: Its headquarters city is unresolved: YC's own directory lists Boston, while a third-party aggregator and the company's own Jobs sub-page list San Francisco, as of July 22, 2026. No source definitively confirms one location.
Has Prescience raised a seed round?: No confirmed funding amount has been reported. Prescience is part of Y Combinator's Summer 2026 batch, which typically includes standard seed investment, but no specific dollar figure or investor names have been disclosed as of July 22, 2026.

Timeline

2026-07-22YC jobs page shows 2 employees total, no open roles posted
2026-07-21Prescience publicly launches via YC Launch YC post, claims payer/provider ambitions
2026-04-30getprescience.com shows vendor claims of 20-50% savings and mock customer dashboard
2026-03-08Sana Benefits reported partnership with PerfectQuote broker platform
2026-01-20Sana Benefits site snapshot shows active small business health plan offering
2025-09-12Founders' prior venture Claisen, Inc. documented with no external funding
2025-03-25Competitor Arlo raises $4M for AI-powered underwriting

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Cosmic Robotics Pango Atlas Discovery